These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4201756)

  • 21. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
    Bendixen M; Dahl S; Fristrup C; Mortensen MB
    Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastasizing primary duodenal cancer. Extended remission in a patient following chemotherapy].
    Neumann R; Common H; Ricken D
    Onkologie; 1986 Oct; 9(5):255-6. PubMed ID: 3101017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
    Carr DT; Childs DS; Lee RE
    Cancer; 1972 Feb; 29(2):375-80. PubMed ID: 4622422
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and management of duodenal adenocarcinomas: a comprehensive review for the radiologist.
    Suh CH; Tirumani SH; Shinagare AB; Kim KW; Rosenthal MH; Ramaiya NH; Baheti AD
    Abdom Imaging; 2015 Jun; 40(5):1110-20. PubMed ID: 25427987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of primary duodenal cancer. Diagnostic and therapeutic considerations].
    Gattoni F; Mazzoni R; Moro E; Frontini L; Uslenghi C
    Radiol Med; 1983 Apr; 69(4):222-3. PubMed ID: 6687946
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case report of primary duodenal adenocarcinoma responding to chemotherapy with S-1 and irinotecan].
    Hadano N; Imamura Y; Nakamitsu A; Koyama M; Uegami S; Kuwada A; Taogoshi H
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):667-71. PubMed ID: 21499002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable.
    Barber TW; Hofman MS; Thomson BN; Hicks RJ
    Eur J Surg Oncol; 2012 Jan; 38(1):64-71. PubMed ID: 21906907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma of the duodenum after trauma, radiotherapy and chemotherapy.
    Bayens YC; Wiggers T; Meerwaldt JH; Vroom TM; Van Geel AN
    Neth J Surg; 1991 Oct; 43(5):181-3. PubMed ID: 1787905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary tumors of the duodenum.
    Chavez CM; Conn JH; Fain WR
    South Med J; 1970 Sep; 63(9):1001-4. PubMed ID: 5460089
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.
    Moertel CG; Childs DS; Reitemeier RJ; Colby MY; Holbrook MA
    Lancet; 1969 Oct; 2(7626):865-7. PubMed ID: 4186452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with the treatment of patients with malignant tumors with 5-fluorouracil].
    Milonov BV; Kosarev VA; Nikiforov AM
    Vopr Onkol; 1967; 13(12):55-61. PubMed ID: 5597532
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.
    Lim YJ; Kim K
    Int J Clin Oncol; 2018 Jun; 23(3):473-481. PubMed ID: 29260430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the duodenum: management and survival in 14 cases.
    Cangemi V; Volpino P; Gentili S; Giuliani A; Di Martino M; Cangemi R; Clementi M; Piat GP
    Panminerva Med; 1997 Mar; 39(1):24-9. PubMed ID: 9175417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant duodenal tumors].
    Søndenaa K; Buanes T; Schistad P; Gerner T
    Tidsskr Nor Laegeforen; 1987 Oct; 107(30):2630-1. PubMed ID: 3424299
    [No Abstract]   [Full Text] [Related]  

  • 37. [Duodenal adenocarcinoma - a case report].
    Stelmaszuk M; Sarosiek T
    Pol Merkur Lekarski; 2018 Feb; 44(260):60-63. PubMed ID: 29498368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary adenocarcinoma of the second portion of duodenum].
    Di Marco L; Berghenti M; Felloni M
    Ann Ital Chir; 2003; 74(5):573-6; discussion 576-7. PubMed ID: 15139715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The diagnostic value of CT in primary carcinoma of the duodenum (report of 5 cases)].
    Lu Y
    Zhonghua Fang She Xue Za Zhi; 1988 Oct; 22(5):283-5. PubMed ID: 2851421
    [No Abstract]   [Full Text] [Related]  

  • 40. Compliance and outcomes of concurrent Chemo-radiation in patients with peri-ampullary cancer undergoing curative resections.
    Pathy S; Mallick S; Sharma A; Shukla NK; Sahni P; Pal S; S Deo SV; Mohanti BK; Upadhyay AD
    Indian J Cancer; 2017; 54(3):519-525. PubMed ID: 29798950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.